3656 results for «335»
3656 results
Featured cases - Strategic approaches in mitral regurgitation
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in this featured session showcasing strategic approaches in the management of mitral regurgitation. Explore a range of complex cases, including percutaneous annuloplasty with a novel device in functional mitral regurgitation, the management of mitral annulus cavity and regurgitation post-healed endocarditis, simultaneous management of two...
Featured research - Tricuspid valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
Delve into the latest research on tricuspid valve interventions in this second featured session from PCR London Valves 2024. Gain insights into the characteristics and outcomes of severe isolated tricuspid regurgitation across different treatment strategies, the issue of valve thrombosis after TTVR, the one-year robustness of...
Featured research - Aortic valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
This second part of the featured research session on aortic valve interventions delves into a wide range of topics, including vascular complications, valve-in-valve TAVI, coronary protection strategies, predictors of mortality, and innovative techniques. Discover the latest advancements and insights from cutting-edge research.
Featured cases - TAVI in bicuspid valve anatomy (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore a unique collection of featured TAVI cases in bicuspid valve anatomy. Witness the successful navigation of complex scenarios, including the treatment of severely calcified bicuspid valves, handling of extreme annular dimensions, and the utilization of specialized techniques like antegrade transseptal TAVI. Gain insights that can...
Featured cases - TAVI in SAVR (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Delve into a collection of compelling TAVI cases involving prior surgical aortic valve replacement (SAVR). Witness the nuances of valve-in-valve TAVI, including the importance of pre-dilation and the challenges of uncrossable valves. Gain insights into managing severe aortic regurgitation in failed bio-Bentall procedures and navigating TAVI...
Featured cases - Complications of mitral TEER
24 Nov 2024 – From PCR London Valves 2024
Delve into a series of compelling cases highlighting complications associated with mitral transcatheter edge-to-edge repair (TEER) procedures. Witness the management of leaflet perforation, single leaflet detachment, and left atrial perforation. Explore innovative bailout strategies and the challenges posed by M-TEER. This session offers valuable lessons to...
Rapid-Fire - Rare and unusual (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in a captivating collection of rare and unusual interventional cardiology cases. Witness the first known case of dual valve-in-valve replacement in caval valve implantation, the management of device-related allergic reactions, and the treatment of left atrial thrombi associated with appendage occlusion devices. Explore solutions...
How to establish a mitral TEER programme
24 Nov 2024 – From PCR London Valves 2024
Ready to start your journey toward establishing a mitral TEER programme? This video covers everything you need to know—from understanding the contemporary role of TEER in managing mitral regurgitation to building a Heart Team and referral network.
Learn how to find your first cases, select the right...
Legal notice
19 Oct 2018
Updated - August 22nd, 2023
AsiaPCR 2018: General Terms and conditions of sale
MASTER-DAPT: “the MASTER of high-bleeding risk trials”
28 Aug 2021
Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.
Author
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
Europa Group's General Terms and Conditions of Sale
12 Apr 2024
Ref 02P - Updated June 2024
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
